Brolucizumab for pre-treated patients with choroidal neovascularization and signs of tachyphylaxis to aflibercept and bevacizumab
Agnes Boltz, Katharina Radunsky, Birgit Weingessel, Veronika Vécsei-Marlovits
Topics & Concepts
AfliberceptMedicineBevacizumabChoroidal neovascularizationOphthalmologyTachyphylaxisMacular degenerationVisual acuityAdverse effectRetinalSurgeryInternal medicineChemotherapyRetinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal Development and Disorders